A recent study reveals that individuals who come off popular weight-loss injections like Wegovy and Mounjaro tend to recover lost weight at a significantly accelerated pace than those who halt conventional diet and exercise plans.
Published data in a major medical journal points out that while obese individuals often shed a large proportion of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month once they quit.
"Users purchasing such drugs need to be cognizant of the potential of quick weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.
That rate of regain means a reversion to original weight within about 18 months.
Analyzing Therapies
The research, which looked at dozens of trials involving thousands of participants, contrasted the outcomes of GLP-1 agonists with other pills.
Researchers point out that people who shed pounds through lifestyle changes alone typically have a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
Explaining the Rapid Regain
Doctors believe the mode of action of the injections explains the amplified rebound.
GLP-1 drugs copy a natural hormone called GLP-1, which moderates hunger.
"Long-term administration of the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means hunger is uncontrolled, making binge eating a significant risk."
A Chronic Condition?
Medical guidelines recommend the jabs for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Many experts say that, given the likelihood of weight regain, the treatment should be considered ongoing.
This opinion is supported by pharmaceutical companies, who state that the findings "underscore the chronic nature of excess weight," comparing it to managing diseases like hypertension.
User Testimonies
Users who have stopped the medication explain a intense return of hunger.
"It felt as if a trigger activating and I was suddenly ravenous," recalled one woman.
The struggle is exacerbated if patients have not established lasting lifestyle or habit modifications during therapy.
Widespread Interest
Figures suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.
- Adoption is higher among females compared to males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, experts stress that while GLP-1 drugs are potent agents for shedding pounds, they are not a permanent cure and maintained weight loss relies on integrated lifestyle support.
